Godavari Drugs Ltd.

BSE: 530317

₹125.18

up-down-arrow ₹15.31 (13.93%)

As on 25-Sep-2026IST

Market cap

info icon

₹137 Cr

Revenue (TTM)

info icon

₹110 Cr

P/E Ratio

info icon

32.9

P/B Ratio

info icon

1.7

Div. Yield

info icon

0 %

Godavari Drugs Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 111.50 High: 130.90

52 Week Range

Low: 69.70 High: 135.25

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹4 Cr

  • ROEROE information

    10.6 %

  • ROCEROCE information

    10.1 %

  • Industry P/EIndustry P/E information

    35.22

  • EV/EBITDAEV/EBITDA information

    18.3

  • Debt to EquityDebt to Equity information

    1.5

  • Book ValueBook Value information

    ₹72.1

  • EPSEPS information

    ₹4.4

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    10,914,125

10 Years Aggregate

CFO

₹69.77 Cr

EBITDA

₹81.50 Cr

Net Profit

₹30.29 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Godavari Drugs
62.9 29.1 1.3 50.7 9.1 12.6 10.5
BSE Healthcare
18.8 2.0 6.2 16.5 22.9 14.5 12.0
As on 25-Sep-2026
Company
2025
2024
2023
2022
2021
2020
2019
Godavari Drugs
-30.6 20.9 -5.1 51.5 62.5 120.1 -31.3
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Godavari Drugs
125.2 136.6 110.0 4.2 6.8 6.4 32.9 1.7
6,505.0 16,294.6 2,432.1 169.6 8.7 20.8 96.1 18.0
2,835.1 21,555.4 2,287.3 678.1 31.4 19.7 32.4 5.9
2,117.7 12,937.5 1,479.1 198.6 18.6 30.3 65 16.0
1,258.9 17,490.1 3,229.7 666.9 26.6 18.8 27.2 4.3
4,000.8 18,323.3 2,569.8 735.2 34.4 19.2 24.9 4.2
5,406.0 8,987.2 1,432.9 356.9 30.8 58.2 25.2 14.6
1,013.5 19,801.7 1,682.5 273.5 21.0 11.1 66.6 7.4
1,184.9 10,915.1 5,004.4 635.3 14.5 19.8 17.8 3.3
985.2 7,926.4 872.6 198.4 29.7 17.4 40 6.5

Shareholding Pattern

View Details
loading...

News & Analysis

All News

No Review & Analysis are available.

About Godavari Drugs

Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid,...  enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services. It serves the life science industry. The company was incorporated in 1987 and is based in Secunderabad, India. 

  • Incorporated

    1987

  • Chairman

    Ghanshyam Jaju

  • Managing Director

    Mukund Kakani

  • Headquarters

    Secunderabad, Telangana

  • Website

    www.godavaridrugs.com

FAQs for Godavari Drugs

The share price of Godavari Drugs Ltd is ₹125.18 (BSE) as of 25-Sep-2026 IST. Godavari Drugs Ltd has given a return of 9.12% in the last 3 years.

The P/E ratio of Godavari Drugs Ltd is 32.87 times as on 25-Sep-2026, a 7 discount to its peers’ median range of 35.22 times.
The P/B ratio of Godavari Drugs Ltd is 1.74 times as on 25-Sep-2026, a 66 discount to its peers’ median range of 5.14 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
15.04
1.52
2024
12.61
1.80
2023
15.07
1.71
2022
9.39
1.66
2021
8.35
1.41

The 52-week high and low of Godavari Drugs Ltd are Rs 135.25 and Rs 69.70 as of 27-Sep-2026.

Godavari Drugs Ltd has a market capitalisation of ₹ 137 Cr as on 25-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Godavari Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...